Modifying effects of ethinylestradiol but not methoxychlor on N-ethyl-N-nitrosourea-induced uterine carcinogenesis in heterozygous p53-deficient CBA mice.

It is unknown whether endocrine-disrupting chemicals (EDCs) with estrogenic activities have any modifying effects on uterine carcinogenesis. In our previous study, we established a uterine-carcinogenesis model that is useful for detecting tumor-modifying effects of EDCs by the administration of N-ethyl-N-nitrosourea (ENU) to female heterozygous p53-deficient CBA mice [p53 (+/-) mice]. To investigate the effects of ethinylestradiol (EE) and methoxychlor (MXC) on development of ENU-induced uterine tumors, female p53 (+/-) mice and their wild-type littermates [p53 (+/+) mice] received an intraperitoneal injection of 120 mg/kg body weight (bw) of ENU, followed, in Group 1, by no further treatment; in Group 2, by a diet containing 1 ppm EE; in Group 3, by a diet containing 5 ppm EE for 4 weeks and 2.5 ppm EE thereafter; and in Group 4, by a diet containing 2000 ppm MXC for 26 weeks. Uterine proliferative lesions that were induced were composed of both endometrial-stromal and epithelial-cell types. Endometrial stromal sarcomas were induced in p53 (+/-) mice of Groups 1 to 4, and the incidence (87%) in Group 3 was significantly increased compared to Group 1 (47%). Atypical hyperplasias (clear-cell type) of the endometrial gland in p53 (+/-) mice were seen at incidences of 0, 14, 60, and 0% in Groups 1, 2, 3, and 4, respectively, while their incidence in p53 (+/+) mice was 0, 7, 53, and 0%, respectively, with a significant difference between Groups 1 and 3 in both cases. One p53 (+/-) mouse in Group 3 also had an adenocarcinoma consisting of clear cells, and the PCNA labeling indices of the clear-cell atypical hyperplasias, and this endometrial adenocarcinoma, were higher than those of glandular hyperplasias. The present study suggests that 2.5 ppm EE, but not MXC, exerts tumor-promoting effects on stromal and epithelial proliferative lesions of the uteri in p53 (+/-) mice initiated with ENU.

[1]  S. Wakana,et al.  Rapid induction of uterine tumors with p53 point mutations in heterozygous p53-deficient CBA mice given a single intraperitoneal administration of N-ethyl-N-nitrosourea. , 2000, Carcinogenesis.

[2]  Midori Yoshida,et al.  Uterine Carcinogenesis by Chemicals/Hormones in Rodents. , 1999 .

[3]  T. Devereux,et al.  Predominant p53 G→A Transition Mutation and Enhanced Cell Proliferation in Uterine Sarcomas of CBA Mice Treated with 1,2-Dimethylhydrazine , 1998, Toxicologic pathology.

[4]  S. Mai,et al.  Genomic instability and apoptosis are frequent in p53 deficient young mice , 1997, Oncogene.

[5]  K. Miyajima,et al.  Rapid and high yield induction of endometrial adenocarcinomas in CD-1 mice by a single intrauterine administration of N-ethyl-N-nitrosourea combined with chronic 17 beta-estradiol treatment. , 1996, Cancer letters.

[6]  J. Li,et al.  Induction of chromosome aberrations in Syrian hamster renal cortical cells by various estrogens. , 1994, Mutation research.

[7]  O. Morozova,et al.  Estrogen modification of 1,2-dimethylhydrazine carcinogenesis in C3HA mice. , 1994, Cancer letters.

[8]  A. Maekawa,et al.  High‐yield Induction of Uterine Endometrial Adenocarcinomas in Donryu Rats by a Single Intra‐uterine Administration of N‐Ethyl‐N‐nitro‐N‐nitrosoguanidine via the Vagina , 1994, Japanese journal of cancer research : Gann.

[9]  T. Dunn,et al.  Tumours of the vagina and uterus. , 1994, IARC scientific publications.

[10]  T. Yagi,et al.  Enhanced proliferative potential in culture of cells from p53-deficient mice. , 1993, Oncogene.

[11]  K. Nelson,et al.  Transforming growth factor-alpha is a potential mediator of estrogen action in the mouse uterus. , 1992, Endocrinology.

[12]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[13]  Takuji Tanaka,et al.  Rapid Induction of Endometrial Carcinoma in ICR Mice Treated with N‐Methyl‐N‐nitrosourea and 17β‐Estradiol , 1991, Japanese journal of cancer research : Gann.

[14]  G. Lucier,et al.  Estrogen receptor, epidermal growth factor receptor and cellular ploidy in elutriated subpopulations of hepatocytes during liver tumor promotion by 17 alpha-ethinylestradiol in rats. , 1991, Carcinogenesis.

[15]  K. Matsumoto,et al.  Experimental induction of uterine cancer in rats by N-ethyl-N'-nitro-N-nitrosoguanidine dissolved in polyethylene glycol. , 1989, Pathology, research and practice.

[16]  G. Stancel,et al.  Regulation of uterine epidermal growth factor (EGF) receptors by estrogen in the mature rat and during the estrous cycle. , 1989, Journal of steroid biochemistry.

[17]  L. Gray,et al.  A dose-response analysis of methoxychlor-induced alterations of reproductive development and function in the rat. , 1989, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[18]  H. Fox.  Endometrial carcinogenesis and its relation to oestrogens. , 1984, Pathology, research and practice.

[19]  H. Mori,et al.  Experimental induction of uterine cancer in rats by N-methyl-N'-nitro-N-nitrosoguanidine. , 1983, Pathology, research and practice.

[20]  Ziel Hk.  Estrogen's role in endometrial cancer. , 1982 .

[21]  C. Lingeman.  Hormones and hormonomimetic compounds in the etiology of cancer. , 1979, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[22]  H. Norris,et al.  Pathologic effects of oral contraceptives. , 1979, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[23]  R. Muccitelli,et al.  Studies on the in vivo and in vitro estrogenic activities of methoxychlor and its metabolites. Role of hepatic mono-oxygenase in methoxychlor activation. , 1978, Biochemical pharmacology.

[24]  W. Deichmann,et al.  Synergism among oral carcinogens. IV. The simultaneous feeding of four tumorigens to rats. , 1967, Toxicology and applied pharmacology.

[25]  J. Radomski,et al.  Synergism among oral carcinogens: I. Results of the simultaneous feeding of four tumorigens to rats , 1965 .

[26]  E. B. Astwood.  A SIX-HOUR ASSAY FOR THE QUANTITATIVE DETERMINATION OF ESTROGEN1 , 1938 .